Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines

Development of resistance to chemo- and radiotherapy in patients suffering from advanced cervical cancer narrows the therapeutic window for conventional therapies. Previously we reported that a combination of the selective BCL-2 family inhibitors ABT-263 and A-1210477 decreased cell proliferation in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biochem Biophys Rep
Hlavní autoři: Abdul Rahman, Siti Fairus, Muniandy, Kalaivani, Soo, Yong Kit, Tiew, Elvin Yu Huai, Tan, Ke Xin, Bates, Timothy E., Mohana-Kumaran, Nethia
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183162/
https://ncbi.nlm.nih.gov/pubmed/32346617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrep.2020.100756
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky